 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ESSA Pharma, Inc. is a clinical stage pharmaceutical company. It focuses on developing novel and proprietary therapies for the treatment of prostate cancer in patients, whose disease is progressing despite treatment with standard of care therapies, including second-generation anti-androgen drugs such as abiraterone, enzalutamide, apalutamide and darolutamide. The company was founded by Marianne D. Sadar and Raymond J. Andersen on January 6, 2009 and is headquartered in Vancouver, Canada.

Current Price	$3.03
Prev Close	$3.15
Open	$3.15
Dividend Yield	0.00%
50-Day Moving Average	$2.90
Beta	1.06
Avg. Volume	79,396.89
PE Ratio	-4.61

52-Week High	$5.92
52-Week Low	$1.40
Market Capitalization	$63.16M
EPS	-$0.6569
Price to Book	0.85
Revenue Per Employee	N/A
Enterprise Value/EBITDA	0.80

EPIX Essa Pharma Inc

About

Feed

Fundamentals

News